	Capital Ordinaire		Date
AbbVie	USD 1.77B	1.75B	2025-06
Acadia Pharmaceuticals	USD 168.71M	104K	2025-09
Akebia Therapeutics	USD 2K	0	2025-03
ALKERMES	USD 165.1M	49K	2025-09
Alnylam Pharmaceuticals	USD 131.79M	130.49M	2025-09
Amarin	USD 20.8M	28K	2025-09
Amgen	USD 539M	1000K	2025-12
Baxter International	USD 683M	0	2024-12
Biogen	USD 146.7M	200K	2025-09
BioMarin Pharmaceutical	USD 192.1M	97K	2025-09
Bristol-Myers Squibb	USD 2.04B	1.74B	2025-09
Coherus Biosciences	USD 12K	0	2025-03
Eli Lilly	USD 946.83M	354.23M	2025-06
Fujifilm	JPY 1.21B	19K	2025-12
Gilead Sciences	USD 1.24B	0	2025-09
Ironwood Pharmaceuticals	USD 160K	0	2024-12
Merck	USD 2.49B	15.79M	2025-09
Myriad Genetics	USD 93.1M	0	2025-09
Pacira	USD 44.9M	44.85M	2025-06
Perrigo	USD 137.6M	0	2025-09
Pfizer	USD 5.69B	1000K	2025-09
PTC Therapeutics	USD 79.93M	554K	2025-09
Regeneron Pharmaceuticals	USD 105.3M	1.1M	2025-09
Sarepta Therapeutics	USD 104.77M	7.06M	2025-09
Teva Pharmaceutical Industries	USD 1.15B	0	2025-12
Vertex Pharmaceuticals	USD 254M	2.29M	2025-09
Xencor	USD 71.34M	46K	2025-09
Zoetis	USD 441.46M	2.48M	2025-09

Coherus Biosciences Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.